<DOC>
	<DOCNO>NCT01424644</DOCNO>
	<brief_summary>The main objective determine whether immune response Tdap ( GlaxoSmithKline , Boostrix® ) HPV vaccine ( Merck &amp; Co. , Inc. , Gardasil® ) administer concomitantly MenACWY comparable response elicit vaccine give alone .</brief_summary>
	<brief_title>A Phase 4 , Placebo-Controlled , Randomized Study Evaluate Immunogenicity Safety HPV Tdap When Administered With MenACWY Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis , Meningococcal</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Individuals eligible enrollment study female male individual show healthy : 1 . 1118 year age inclusive give write consent/assent applicable , whose parent legal guardian give write informed consent time enrollment ; Available visit telephone call schedule study ; In good health determine : Medical history Physical assessment Clinical judgment investigator 2 . Had properly vaccinate diphtheria , tetanus , pertussis per local regulation ; 3 . Subjects current childhood DTPcontaining vaccination per local guideline . Any previous vaccination contain DTP must receive least 5 year study enrollment prior adolescent vaccination ( 1118 year age ) contain DTP vaccine allow . 4 . For female subject , negative urine pregnancy test . 5 . Any female subject sexually active committed practice appropriate birth control . Individuals eligible enrol study : 1. Who unwilling give write assent / consent 2. Who breastfeed 3. Who , and/or whose parent legal guardian perceive unreliable unavailable duration study period 4. Who previous confirm suspected disease cause N. meningitidis 5. Who household contact and/or intimate exposure individual cultureproven N. meningitidis infection within 60 day prior enrollment 6. Who previously immunize meningococcal vaccine vaccine contain meningococcal antigen ( ) ( licensed investigational ) . ( Exception : Receipt OMPcontaining Hib vaccine permit ) 7. Who receive prior human papillomavirus ( HPV ) vaccine 8. Who receive investigational agent vaccine within 30 day prior enrollment expect receive investigational agent vaccine prior completion study 9. Who receive live license vaccine within 30 day inactive vaccine within 15 day prior enrollment receipt license vaccine anticipate study period . ( Exception : Influenza vaccine could administer 15 day prior study immunization le 15 day study vaccination ) 10. Who experience , within 7 day prior enrollment , significant acute chronic infection ( example require systemic antibiotic treatment antiviral therapy ) experience fever ( define body temperature ≥ 38°C ) within 3 day prior enrollment 11. Who serious acute , chronic progressive disease History cancer Complicated diabetes mellitus Advanced arteriosclerotic disease Autoimmune disease HIV infection AIDS Blood dyscrasia Congestive heart failure Renal failure Severe malnutrition ( Note : Subjects mild asthma eligible enrollment . Subjects moderate severe asthma require routine use inhale systemic corticosteroid eligible enrollment ) 12. Who epilepsy , progressive neurological disease history GuillainBarre syndrome 13. Who history anaphylaxis , serious vaccine reaction , allergy vaccine component , include latex allergy 14. Who know suspected impairment/alteration immune function , either congenital acquire result ( example ) : Receipt immunosuppressive therapy within 30 day prior enrollment ( systemic corticosteroid administer 5 day , daily dose &gt; 1 mg/kg/day prednisone equivalent 30 day prior enrollment , cancer chemotherapy ) Receipt immunostimulants Receipt parenteral immunoglobulin preparation , blood product , and/or plasma derivative within 90 day prior enrollment full length study 15. Who know bleed diathesis , condition may associate prolonged bleeding time ; 16. Who Down 's syndrome know cytogenic disorder ; 17. Who and/or whose family plan leave area study site end study period ; 18. Who condition , opinion investigator , might interfere evaluation study objective . 19. Who relatives study personnel .</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>meningitis</keyword>
	<keyword>human papillomavirus</keyword>
	<keyword>tetanus</keyword>
	<keyword>diptheria</keyword>
	<keyword>pertussis</keyword>
</DOC>